Mega Genomics Limited (HKG:6667)
7.19
+0.02 (0.28%)
Sep 11, 2026, 3:51 PM HKT
Mega Genomics Revenue
Mega Genomics had revenue of 192.50M CNY in the half year ending June 30, 2026, with 79.42% growth. This brings the company's revenue in the last twelve months to 358.37M, up 159.28% year-over-year. In the year 2025, Mega Genomics had annual revenue of 247.15M with 50.49% growth.
Revenue (ttm)
358.37M CNY
Revenue Growth
+159.28%
P/S Ratio
3.89
Revenue / Employee
1.74M CNY
Employees
206
Market Cap
1.61B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 247.15M | 82.92M | 50.49% |
| Dec 31, 2024 | 164.23M | 12.93M | 8.54% |
| Dec 31, 2023 | 151.30M | 5.57M | 3.82% |
| Dec 31, 2022 | 145.73M | -91.46M | -38.56% |
| Dec 31, 2021 | 237.19M | 33.97M | 16.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 8.02B |
| Adicon Holdings | 3.06B |
| Kindstar Globalgene Technology | 1.10B |
| Yunkang Group | 624.49M |
| Biosino Bio-Technology and Science Incorporation | 196.98M |
| Zhong Ji Longevity Science Group | 150.07M |
| King International Investment | 143.23M |
| Guanze Medical Information Industry (Holding) | 98.16M |